Literature DB >> 8480637

Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia.

R Pedretti1, M D Etro, A Laporta, S Sarzi Braga, B Carù.   

Abstract

A combined use of noninvasive techniques and electrophysiologic study in the prediction of arrhythmic events was prospectively evaluated in 303 surviving patients of acute myocardial infarction (AMI). The most powerful combination of noninvasive prognostic variables in identifying patients suitable for invasive strategies was also assessed. Patients who had > or = 2 variables among left ventricular ejection fraction < 0.4, ventricular late potentials and repetitive ventricular premature complexes (VPCs) were considered eligible for programmed ventricular stimulation. After 15 +/- 7 months of follow-up, 19 patients (6%) had an arrhythmic event. Left ventricular dyskinesia (p < 0.00001) and ejection fraction < 0.4 (p < 0.000001), late potentials (p < 0.001), filtered QRS duration > or = 106 ms (p < 0.00001), VPCs/hour > 6 (p < 0.05), paired VPCs (p < 0.01), > or = 2 runs of unsustained ventricular tachycardia (VT) per monitoring (p < 0.001), heart rate variability index < or = 29 (p < 0.00001) and mean RR interval < or = 750 ms (p < 0.01) were found to be significant univariate predictors of events. At multivariate analysis, only low left ventricular ejection fraction, prolonged filtered QRS duration, reduced heart rate variability index and detection of > or = 2 runs of unsustained VT per monitoring had an independent relation to late arrhythmic events. Of 67 eligible patients, 47 (70%) consented to undergo programmed stimulation. A positive electrophysiologic study was found to be the strongest independent predictor of events among patients preselected by noninvasive techniques. With a good sensitivity (81%), a combined use of noninvasive tests and electrophysiologic study selected a group of post-AMI patients at sufficiently high risk (event rate 65%) to be considered candidates for interventional therapy. The combination of > or = 2 variables among left ventricular ejection fraction < 0.4, filtered QRS duration > or = 106 ms and > or = 2 runs of unsustained VT was superior to the other ones in identifying high-risk subjects (positive and negative predictive values for arrhythmic events of 44 and 99%, respectively). On the basis of the data, this scheme appears to be the most appropriate for selecting patients suitable for electrophysiologic testing and invasive strategies after AMI.

Entities:  

Mesh:

Year:  1993        PMID: 8480637     DOI: 10.1016/0002-9149(93)90635-p

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

Review 1.  The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's.

Authors:  A Capucci; D Aschieri; G Q Villani
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 2.  The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia.

Authors:  J A Gomes
Journal:  Curr Cardiol Rep       Date:  1999-11       Impact factor: 2.931

Review 3.  Hypertension, left ventricular hypertrophy, and sudden death.

Authors:  Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 4.  [Long term electrocardiography (Holter monitoring)].

Authors:  Axel Brandes; Klaus-Peter Bethge
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-10-25

5.  Significance of perfusion of the infarct related coronary artery for susceptibility to ventricular tachyarrhythmias in patients with previous myocardial infarction.

Authors:  H V Huikuri; M J Koistinen; K E Airaksinen; M J Ikäheimo
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 6.  Risk stratification after myocardial infarction: role of electrical instability, ischemia, and left ventricular function.

Authors:  A Bayés-de-Luna; X Viñolas; J Guindo; A Bayés-Genis
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

7.  [Effect of physical activity on incidence of sudden cardiac death. Study of the Berlin-Reinickendorf and Berlin-Spandau population].

Authors:  R Bartels; M Menges; W Thimme
Journal:  Med Klin (Munich)       Date:  1997-06-15

8.  Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.

Authors:  Konstantinos A Gatzoulis; Dimitrios Tsiachris; Petros Arsenos; Christos-Konstantinos Antoniou; Polychronis Dilaveris; Skevos Sideris; Emmanuel Kanoupakis; Emmanouil Simantirakis; Panagiotis Korantzopoulos; Ioannis Goudevenos; Panagiota Flevari; Efstathios Iliodromitis; Antonios Sideris; Vassilios Vassilikos; Nikolaos Fragakis; Konstantinos Trachanas; Michail Vernardos; Ioannis Konstantinou; Konstantinos Tsimos; Iosif Xenogiannis; Konstantinos Vlachos; Athanasios Saplaouras; Konstantinos Triantafyllou; Ioannis Kallikazaros; Dimitrios Tousoulis
Journal:  Eur Heart J       Date:  2019-09-14       Impact factor: 29.983

Review 9.  Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach.

Authors:  Petros Arsenos; Konstantinos A Gatzoulis; Dimitrios Tsiachris; Polychronis Dilaveris; Skevos Sideris; Ilias Sotiropoulos; Stefanos Archontakis; Christos-Konstantinos Antoniou; Athanasios Kordalis; Ioannis Skiadas; Konstantinos Toutouzas; Charalambos Vlachopoulos; Dimitrios Tousoulis; Konstantinos Tsioufis
Journal:  World J Cardiol       Date:  2022-03-26

10.  Arrhythmic risk stratification in heart failure mid-range ejection fraction patients with a non-invasive guiding to programmed ventricular stimulation two-step approach.

Authors:  Petros Arsenos; Konstantinos A Gatzoulis; Ioannis Doundoulakis; Polychronis Dilaveris; Christos-Konstantinos Antoniou; Soulaidopoulos Stergios; Skevos Sideris; Sotiropoulos Ilias; Dimitrios Tousoulis
Journal:  J Arrhythm       Date:  2020-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.